SELE and leukemia: Morita et al. have shown that the suppression of E-Selectin by RUNX inhibitors can significantly prolong survival by inhibiting the pooling of leukemic cells in the bone marrow and facilitating the exposure of leukemic cells released into the circulating blood to anticancer therapy, suggesting one possible way to overcome MRD in leukemia [68].